glp-1 purpose Receptor Agonists as Treatments for Type 2 Diabetes GLP-1 Agonists in Cardiovascular Diseases:

GLP-1 analogues delay gastric emptying ( When initiating GLP-1based therapy, clinicians should adhere to the principle of do no harm , particularly during the early phases of treatment when gastrointestinal adverse effects are most likely to emerge ( Potentially the easiest way to prevent nausea and vomiting is by starting at a low dose ( In most cases of Grade 1 or 2 nausea, maintaining the current dose for one to two additional dosing intervals is sufficient to allow symptom resolution

common side effects include mild nausea, rash, constipation or gas

It happens because of UV rays from the sun, which can slow your progress and may lead to increased pigmentation

This leads to more stable energy levels and less chance of the sugar crash that can trigger nausea

Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment